Finance

Beta
Lists
TVRD:NASDAQ
Tvardi Therapeutics Inc
$3.38
-3.30%
(-0.12) 1D
May 29, 12:53:51 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TVRD...
Open
$3.47
High
$3.47
Low
$3.32
Mkt. cap
31.66M
Avg. vol.
44.15K
Volume
21.67K
52-wk high
$43.65
52-wk low
$2.75
EPS
-$1.60
Beta
0.30
Shares outstanding
9.38M
No. of employees
12
Open
$3.47
High
$3.47
Low
$3.32
Mkt. cap
31.66M
Avg. vol.
44.15K
Volume
21.67K
52-wk high
$43.65
52-wk low
$2.75
EPS
-$1.60
Beta
0.30
Shares outstanding
9.38M
No. of employees
12
News stories
From sources across the web
About Tvardi Therapeutics Inc
CEO-
Employees12
Founded2017
HeadquartersSugar Land, Texas, United States
SectorPharmaceutical industry
Websitetvarditherapeutics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.81M
3.60M
5.49M
4.91M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.06M
2.34M
2.10M
2.14M
Operating expense
8.87M
5.94M
7.59M
7.05M
Total operating expenses
8.87M
5.94M
7.59M
7.05M
Operating income
-8.87M
-5.94M
-7.59M
-7.05M
Other non operating income
12.66M
-
-
-
EBT including unusual items
4.17M
-5.53M
-7.28M
-6.80M
EBT excluding unusual items
4.17M
-5.53M
-7.28M
-6.80M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
4.17M
-5.53M
-7.28M
-6.80M
Net profit margin
-
-
-
-
Earnings per share
0.51
-0.59
-0.78
-0.73
Interest and investment income
377.00K
411.00K
312.00K
247.00K
Interest expense
-
-
-
-
Net interest expenses
377.00K
411.00K
312.00K
247.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.85M
-5.91M
-7.56M
-7.03M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer